Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life Expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–16.
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015;373:808–22.
Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. Lancet HIV. 2019;6:e93–104.
Article PubMed PubMed Central Google Scholar
Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in people living with HIV: systematic review and Meta-analysis. Circulation. 2018;138:1100–12.
Article PubMed PubMed Central Google Scholar
Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614–22.
Article CAS PubMed PubMed Central Google Scholar
Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151:1147–55.
Naidu S, Ponnampalvanar S, Kamaruzzaman SB, Kamarulzaman A. Prevalence of metabolic syndrome among people living with HIV in developing countries: a systematic review. AIDS Patient Care STDs. 2017;31:1–13.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.
Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Translational Res. 2017;183:57–70.
Abate N. Obesity and cardiovascular disease: pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complicat. 2000;14:154–74.
Rönsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR. Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy. PLoS ONE. 2013;8:e65182.
Article PubMed PubMed Central Google Scholar
Thet D, Siritientong T. Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies. HIV/AIDS - Research and Palliative Care. 2020;12:507–24.
Alencastro PR, Fuchs SC, Wolff FH, Ikeda ML, Brandão ABM, Barcellos NT. Independent predictors of metabolic syndrome in HIV-Infected patients. AIDS Patient Care STDs. 2011;25:627–34.
Jericó C, Knobel H, Montero M, Ordoñez-Llanos J, Guelar A, Gimeno JL, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care. 2005;28:132–7.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.
Article CAS PubMed Google Scholar
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of Hypertriglyceridemia: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97:2969–89.
Article CAS PubMed PubMed Central Google Scholar
Singh V, Sharma R, Kumar A, Deedwania P. Low high-density lipoprotein cholesterol: current status and future strategies for management. Vasc Health Risk Manag. 2010;6:979–96.
Article CAS PubMed PubMed Central Google Scholar
Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30:160–4.
Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and management. Diabetes Vascular Disease Res. 2005;2:9–15.
Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2012;35:S64–71.
Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–55.
Article CAS PubMed PubMed Central Google Scholar
Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M. Increase in Non-AIDS related conditions as causes of death among HIV-Infected individuals in the HAART era in Brazil. PLoS ONE. 2008;3:e1531.
Article PubMed PubMed Central Google Scholar
Ascaso JF, Romero P, Real JT, Lorente RI, Martínez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003;14:101–6.
Article CAS PubMed Google Scholar
Paula AA, Falcão MC, Pacheco AG. Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Therapy. 2013;10:32.
Nasi M, Pinti M, Mussini C, Cossarizza A. Persistent inflammation in HIV infection: established concepts, new perspectives. Immunol Lett. 2014;161:184–8.
Article CAS PubMed Google Scholar
Chammartin F, Darling K, Abela IA, Battegay M, Furrer H, Calmy A, et al. CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: the Swiss HIV Cohort Study. JAIDS J Acquir Immune Defic Syndr. 2022;91:508.
Article CAS PubMed Google Scholar
Gojak R, Hadžiosmanović V, Baljić R, Zečević L, Ćorić J, Mijailović Ž. CD4/CD8 ratio as a predictor for the occurrence of metabolic syndrome in HIV / AIDS patients during 6 months of cART therapy. J Med Biochem. 2019;38:489–95.
Article CAS PubMed PubMed Central Google Scholar
Mazzitelli M, Fusco P, Brogna M, Vallone A, D’Argenio L, Beradelli G, et al. Weight of clinical and social determinants of metabolic syndrome in people living with HIV. Viruses-Basel. 2022;14:8.
Quiros-Roldan E, Magro P, Raffetti E, Izzo I, Borghetti A, Lombardi F, et al. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015. BMC Infect Dis. 2018;18:285.
Article PubMed PubMed Central Google Scholar
Dock JN, Effros RB. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Disease. 2011;2:382.
PubMed PubMed Central Google Scholar
Whitfield JB. Gamma Glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263–355.
Article CAS PubMed Google Scholar
Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130–7.
Article CAS PubMed Google Scholar
Liu C-F, Zhou W-N, Fang N-Y. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Int J Clin Pract. 2012;66:692–8.
Article CAS PubMed Google Scholar
Lee MY, Koh SB, Koh JH, Nam SM, Shin JY, Shin YG, et al. Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean population. Diabet Med. 2008;25:469–75.
留言 (0)